Effect of tourniquet time on short-term outcome after TKA

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005631

Enrollment

100

Registered

2020-11-24

Start date

2020-10-22

Completion date

Unknown

Last updated

2020-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : -In the experimental group, the tourniquet is used only from skin incision to just before the bone resection is performed. In this case, the tourniquet usage time is expected to be ar

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients who underwent primary total knee arthroplasty due to end-stage osteoarthritis

Exclusion criteria

Exclusion criteria: Arthritis other than primary osteoarthritis (rheumatoid arthritis, psoriatic arthritis, gouty arthritis, lupus arthritis, infectious arthritis, etc.) Coagulopathy Atrial fibrillation History of DVT, PE, MI, CVA Severe renal failure (eGFR <30 ml/min) Anemia (Hb < 11g/dL) Current anticoagulation therapy Current P2Y12 inhibitors Tx. General anesthesia

Design outcomes

Primary

Measure	Time frame
Hb drop	—

Secondary

Measure	Time frame
Pain (VAS score)	—

Countries

Korea, Republic of

Contacts

Public ContactSeong In Lee

Seoul National University Bundang Hospital

Outcome results